T1	Participants 296 362	101 patients with high-risk breast cancer after surgical resection
T2	Participants 398 466	patients were divided into two groups: dose-dense and regular groups
T3	Participants 973 985	101 patients
T4	Participants 1254 1312	Ninety-eight patients completed the chemotherapy as planed
